Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.

Signal Transduct Target Ther

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.

Published: July 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11246411PMC
http://dx.doi.org/10.1038/s41392-024-01910-4DOI Listing

Publication Analysis

Top Keywords

correction melk
4
melk oncogenic
4
oncogenic kinase
4
kinase essential
4
essential metastasis
4
metastasis mitotic
4
mitotic progression
4
progression programmed
4
programmed death
4
death lung
4

Similar Publications

Background: Left ventricular hypertrophy (LVH) in patients with end stage renal disease undergoing renal replacement is linked to an increased risk for cardiovascular diseases. Dialysis does not completely prevent or correct this abnormality, and the evidence for kidney transplantation (KT) varies. This analysis aims to explore the relationship between KT and LVH.

View Article and Find Full Text PDF

Arterial Stiffness and Chronic Kidney Disease Progression in Children.

Clin J Am Soc Nephrol

October 2022

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany.

Background And Objectives: CKD has been linked to increased arterial stiffness in adults, but data in children with CKD remain conflicting. We aimed to investigate the longitudinal dynamics and determinants of pulse wave velocity in children with CKD and its association with CKD progression.

Design, Setting, Participants, & Measurements: We performed an analysis of the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study, which prospectively followed children aged 6-17 years with CKD stages 3-5.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!